Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Herpes simplex virus VP16 vaccines

Herpes simplex virus VP16 vaccines

US Patent 5795579 · Granted Aug 18, 1998

Estimated economic value: $23,771,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bioadhesive delivery system for transmucosal delivery of beneficial agents2009
Factor VIII:C nucleic acid molecules2006
Herpes simplex virus VP22 vaccines and methods of use2003
Protein complexes having factor VIII:C activity and production thereof2001
Secreted viral proteins useful for vaccines and diagnostics2000
Protein complexes having Factor VIII:C activity and production thereof2000
Herpes simplex virus diagnostics1999
Protein complexes having factor VIII:C activity and production thereof1998
Expression of recombinant glycoprotein B from herpes simplex virus1998
Recombinant herpes simplex gB-gD vaccine1998
Recombinant herpes simplex gB-gD vaccine1998
Herpes simplex virus VP16 vaccines1998